Antibody response and plasma Aβ1-40 levels in young Microcebus murinus primates immunized with Aβ1-42 and its derivatives
- 11 February 2009
- journal article
- research article
- Published by Elsevier BV in Vaccine
- Vol. 27 (7), 957-964
- https://doi.org/10.1016/j.vaccine.2008.12.012
Abstract
No abstract availableThis publication has 39 references indexed in Scilit:
- Mechanisms of Disease: the role of gastrointestinal hormones in appetite and obesityNature Clinical Practice Gastroenterology & Hepatology, 2008
- Immunotherapy Targeting Pathological Tau Conformers in a Tangle Mouse Model Reduces Brain Pathology with Associated Functional ImprovementsJournal of Neuroscience, 2007
- Microtubule-associated protein tau as a therapeutic target in neurodegenerative diseaseEmerging Therapeutic Targets, 2007
- Vaccination of Alzheimer's model mice with Aβ derivative in alum adjuvant reduces Aβ burden without microhemorrhagesEuropean Journal of Neuroscience, 2006
- Short Amyloid-β (Aβ) Immunogens Reduce Cerebral Aβ Load and Learning Deficits in an Alzheimer's Disease Mouse Model in the Absence of an Aβ-Specific Cellular Immune ResponseJournal of Neuroscience, 2006
- An Attenuated Immune Response Is Sufficient to Enhance Cognition in an Alzheimer's Disease Mouse Model Immunized with Amyloid-β DerivativesJournal of Neuroscience, 2004
- Alzheimer Aβ Vaccination of Rhesus Monkeys (Macaca Mulatta)Alzheimer Disease & Associated Disorders, 2004
- Reduction of β-amyloid plaques in brain of transgenic mouse model of Alzheimer’s disease by EFRH-phage immunizationVaccine, 2003
- Local and distant histopathological effects of unilateral amyloid-β 25–35 injections into the amygdala of young F344 ratsNeurobiology of Aging, 1996
- Senile plaques and neurofibrillary changes in the brain of an aged lemurian primate, Microcebus murinusNeurobiology of Aging, 1992